VR Adviser as of June 30, 2022
Portfolio Holdings for VR Adviser
VR Adviser holds 27 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tricida | 13.6 | $69M | 7.1M | 9.68 | |
| Aclaris Therapeutics (ACRS) | 12.5 | $64M | 4.6M | 13.96 | |
| Relmada Therapeutics (RLMD) | 8.5 | $43M | 2.3M | 18.99 | |
| Travere Therapeutics (TVTX) | 8.2 | $42M | 1.7M | 24.23 | |
| Cogent Biosciences (COGT) | 7.2 | $36M | 4.0M | 9.02 | |
| GH Research Ord Sh (GHRS) | 6.3 | $32M | 3.2M | 9.98 | |
| Instil Bio | 5.5 | $28M | 6.0M | 4.62 | |
| Celldex Therapeutics (CLDX) | 4.6 | $23M | 865k | 26.96 | |
| Miragen Therapeutics (VRDN) | 4.2 | $21M | 1.9M | 11.57 | |
| Vistagen Therapeutics | 3.6 | $18M | 21M | 0.88 | |
| Marinus Pharmaceuticals (MRNS) | 3.0 | $15M | 3.2M | 4.84 | |
| Aadi Bioscience (AADI) | 2.8 | $15M | 1.2M | 12.32 | |
| Inozyme Pharma (INZY) | 2.5 | $13M | 2.7M | 4.77 | |
| Akouos | 2.5 | $13M | 2.7M | 4.69 | |
| LianBio Spons Adr (LIANY) | 2.3 | $12M | 5.4M | 2.16 | |
| Aerovate Therapeutics (AVTE) | 1.8 | $9.2M | 590k | 15.63 | |
| Trevi Therapeutics (TRVI) | 1.7 | $8.6M | 3.1M | 2.81 | |
| Chinook Therapeutics | 1.7 | $8.6M | 490k | 17.49 | |
| Annexon (ANNX) | 1.4 | $7.3M | 1.9M | 3.77 | |
| Savara (SVRA) | 1.2 | $6.3M | 4.1M | 1.52 | |
| Lyra Therapeutics (LYRA) | 1.0 | $5.2M | 924k | 5.65 | |
| Provention Bio | 0.9 | $4.5M | 1.1M | 4.00 | |
| Altimmune (ALT) | 0.9 | $4.3M | 369k | 11.70 | |
| Atyr Pharma (LIFE) | 0.8 | $4.0M | 1.4M | 2.83 | |
| Affimed Therapeutics B V | 0.8 | $4.0M | 1.4M | 2.77 | |
| Rallybio Corp (RLYB) | 0.4 | $2.0M | 269k | 7.55 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $913k | 30k | 30.43 |
